Case studies
Representative, anonymised engagements across UK, EU and US portfolios. Each figure was measured and signed off in the client’s ledger. Full detail available under NDA.
US$128M delivered against a US$120M target (107%), independently verified by the client’s external auditor. Span of control widened from 5.1 to 5.8 across 31 markets, with the saving tracked on the EBITDA bridge.
Verified outcome27 late milestones cleared under new governance after RCK mobilised on the engagement.
Verified outcomePre-vetted partners across 12+ workstreams, in seat in Week 1 of engagement.
Verified outcomeTSA execution and stranded-cost removal delivered against agreed exit gates.
Verified outcomeA $250M pharma carve-out delivered across 7 sites, on time and on the agreed terms.
Verified outcomeSales-force and go-to-market alignment held customer retention through the close.
Verified outcomeA €450M industrial carve-out separated four months ahead of schedule, eliminating €8.2M of TSA run-rate cost.
Verified outcomeA £200M-revenue group realised £18M of GL-verified EBITDA improvement across 14 European operating entities.
Verified outcomeAnonymised and representative of engagement type. Full detail available under NDA.
Your deal next
Bring your thesis. We will scope the milestones and the 40/60 model against it.